Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chackalamannil

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometryYunsheng Hsieh, Gangfeng Wang, Yuguang Wang, et al.
Current Pharmaceutical Design|July 16, 2009
The role of exploratory drug metabolism and pharmacokinetics in new drug research: case study-selection of a thrombin receptor antagonist for developmentYunsheng Hsieh, K-C Cheng, Yuguang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitorsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
The Journal of Organic Chemistry|October 25, 2001
Total Synthesis of (+)-Himbacine and (+)-HimbelineSamuel Chackalamannil, Robert J. Davies, Yuguang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Sulfide analogues as potent and selective M(2) muscarinic receptor antagonistsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxarMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
The Journal of Organic Chemistry|February 16, 2002
Synthesis of mono- and difluoronaphthoic acidsJayaram R Tagat, Stuart W McCombie, Dennis V Nazareno, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of P2-P4 Macrocycles Containing a Unique Spirocyclic Proline: A New Class of HCV NS3/4A InhibitorsFrancisco Velázquez, Mariappan Chelliah, Martin Clasby, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxarMariappan V Chelliah, Keith Eagen, Zhuyan Guo, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Discovery of a vorapaxar analog with increased aqueous solubilityYan Xia, Samuel Chackalamannil, William J Greenlee, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometryYunsheng Hsieh, Gangfeng Wang, Yuguang Wang, et al.
Current Pharmaceutical Design|July 16, 2009
The role of exploratory drug metabolism and pharmacokinetics in new drug research: case study-selection of a thrombin receptor antagonist for developmentYunsheng Hsieh, K-C Cheng, Yuguang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitorsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
The Journal of Organic Chemistry|October 25, 2001
Total Synthesis of (+)-Himbacine and (+)-HimbelineSamuel Chackalamannil, Robert J. Davies, Yuguang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Sulfide analogues as potent and selective M(2) muscarinic receptor antagonistsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxarMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
The Journal of Organic Chemistry|February 16, 2002
Synthesis of mono- and difluoronaphthoic acidsJayaram R Tagat, Stuart W McCombie, Dennis V Nazareno, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of P2-P4 Macrocycles Containing a Unique Spirocyclic Proline: A New Class of HCV NS3/4A InhibitorsFrancisco Velázquez, Mariappan Chelliah, Martin Clasby, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxarMariappan V Chelliah, Keith Eagen, Zhuyan Guo, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Discovery of a vorapaxar analog with increased aqueous solubilityYan Xia, Samuel Chackalamannil, William J Greenlee, et al.
Pageof 5